Close
4

Athena Athena

X

Company profile for Advanced Accelerator Applications

Client Virtual Booth
  • Webinars & Exhibitions

PharmaCompass
About the Company
Our work is guided by our commitment to bring new innovations to patients and AAA is dedicated to developing treatments for several leading types of cancer through the application of precision, targeted radioligand therapy. Our ambition is to leverage industry leading pipeline to unlock the benefit of radioligand therapy across different tumor types. Our goal is to reimagine nuclear medicine. All of our manufacturing facilitie...
Our work is guided by our commitment to bring new innovations to patients and AAA is dedicated to developing treatments for several leading types of cancer through the application of precision, targeted radioligand therapy. Our ambition is to leverage industry leading pipeline to unlock the benefit of radioligand therapy across different tumor types. Our goal is to reimagine nuclear medicine. All of our manufacturing facilities conform to current good manufacturing practices or cGMP. This network provides the basis for our advanced manufacturing capacity, cost-efficient production, and organization of reliable product distribution.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Advanced Accelerator Applications
France Flag
Country
Country
France
Address
Address
20 Rue Diesel 01630 Saint-Genis-Pouilly
Telephone
Telephone
+33(0)450993070

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY